Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Soft Tissue Tumors: Unveiling the Complexity and Advancing Patient Care

Kim Sun

Soft tissue tumors represent a heterogeneous group of neoplasms originating from non-epithelial structures, presenting diagnostic and therapeutic challenges. This abstract highlights the complexity of soft tissue tumors and discusses recent advancements in patient care. Molecular profiling techniques have revolutionized our understanding of these tumors, identifying molecular alterations and signaling pathways that guide personalized treatment approaches. Multimodal treatment strategies, including surgery, radiation therapy, and systemic therapies, are employed to optimize patient outcomes. Emerging therapeutic strategies, such as immunotherapy and targeted therapies, show promise in improving outcomes for patients with soft tissue tumors. Collaboration among various disciplines and the establishment of registries and networks facilitate comprehensive patient evaluation and foster research. By unveiling the complexity of soft tissue tumors and advancing patient care, we strive to improve treatment outcomes and provide personalized interventions in this challenging field.